Aigen Investment Management, LP Charles River Laboratories International, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$206.39 - $268.73 $298,233 - $388,314	1,445 New	1,445 $298,000
Q2 2022 Aug 02, 2022	SELL	$204.13 - $302.4 $818,765 - $1.21 Million	-4,011 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$255.51 - $362.11 $507,698 - $719,512	1,987 Added 98.17%	4,011 $1.14 Million
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $711,193 - $908,128	2,024 New	2,024 $733,000
Q2 2020 Aug 10, 2020	SELL	$118.84 - $189.72 $16,281 - $25,991	-137 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$98.9 - $178.34 $13,549 - $24,432	137 New	137 $17,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.